Autologous IL-2 and CD40 ligand–expressing tumor cell vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous IL-2 and CD40 ligand–expressing tumor cell vaccine, covering 2012-05-21 to 2012-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Lymphocytic B-Leukemia (B-CLL) w/Human IL-2 Gene Modified & Human CD40 Ligand-Expressing Autologous Tumor Cells [Phase 1]